Compounds > fulvestrant
Page last updated: 2024-08-26

fulvestrant and Lymph Node Metastasis

fulvestrant has been researched along with Lymph Node Metastasis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Cao, Y; Ding, J; Fu, W; Guo, Y; Jiang, X; Li, K1
Baena-Cañada, JM; Bayo, JL; Blancas, I; Bofill, JS; Carabantes, F; Conde, V; Cruz, J; Esquerdo, G; Fontanillas, M; García-Palomo, A; Gordon, MM; Illarramendi, JJ; Jaen, A; Jáñez, NM; Lao, J; Martínez, E; Mendiola, C; Pérez-Ruiz, E; Ruiz-Borrego, M; Sotelo, MJ1
Chesney, J; Clem, AL; Clem, BF; Imbert-Fernandez, Y; Kerr, DA; Lanceta, L; O'Neal, J; Spaulding, R; Telang, S1
Fan, S; Jiang, Z; Liao, Y; Liu, C; Tang, H; Wang, J; Xiong, J; Zhou, B; Zhou, S; Zou, M1
Flemming, J; Franek, JA; Madarnas, Y1
Brennan, DJ; Crown, JP; Gallagher, WM; Gremel, G; Higgins, DG; Jirström, K; Madden, SF; Martin, F; McGee, SF; McNally, S; Mulrane, L; O'Connor, DP1

Reviews

1 review(s) available for fulvestrant and Lymph Node Metastasis

ArticleYear
Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review.
    Breast cancer research and treatment, 2009, Volume: 115, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Estradiol; Female; Fulvestrant; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Postmenopause

2009

Other Studies

5 other study(ies) available for fulvestrant and Lymph Node Metastasis

ArticleYear
Concomitant fulvestrant with reirradiation for unresectable locoregional recurrent estrogen receptor positive (ER+) breast cancer: A case report and narrative review.
    Medicine, 2020, Jul-24, Volume: 99, Issue:30

    Topics: Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Middle Aged; Narrative Medicine; Neoplasm Recurrence, Local; Re-Irradiation; Receptors, Estrogen

2020
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2018, Volume: 20, Issue:7

    Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Drug Resistance, Neoplasm; Estradiol; Female; Follow-Up Studies; Fulvestrant; Humans; Lymphatic Metastasis; Middle Aged; Postmenopause; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies

2018
Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
    The Journal of biological chemistry, 2014, Mar-28, Volume: 289, Issue:13

    Topics: Apoptosis; Biological Transport; Breast Neoplasms; Cell Survival; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Fructosediphosphates; Fulvestrant; Gene Expression Regulation, Neoplastic; Glucose; Glycolysis; Humans; Lymphatic Metastasis; MCF-7 Cells; Phosphofructokinase-2; Response Elements

2014
G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:4

    Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Blotting, Western; Carcinogens; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Movement; Cell Proliferation; Cyclopentanes; Disease Progression; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Middle Aged; Neoplasm Staging; Phosphorylation; Prognosis; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; RNA, Small Interfering; Tissue Array Analysis; Tumor Cells, Cultured; Urethane; Xenograft Model Antitumor Assays

2015
miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Dec-15, Volume: 18, Issue:24

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Movement; Cell Survival; Disease-Free Survival; Estradiol; Female; Fulvestrant; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; MCF-7 Cells; MicroRNAs; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Oligonucleotide Array Sequence Analysis; Proportional Hazards Models; Tamoxifen; Tissue Array Analysis; Transcriptome; Treatment Outcome

2012